−58.70MXN
−2.29 BMXN
5.25 BMXN
41.10 M
About CARDLYTICS INC
Sector
Industry
CEO
Karim Temsamani
Website
Headquarters
Atlanta
Employees (FY)
434
Founded
2008
Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates under the Cardlytics and Bridg Platforms. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CDLX is 107.40 MXN — it has decreased by 52.27% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange CARDLYTICS INC stocks are traded under the ticker CDLX.
CARDLYTICS INC is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
CDLX stock is 109.50% volatile and has beta coefficient of 2.93. Check out the list of the most volatile stocks — is CARDLYTICS INC there?
CDLX earnings for the last quarter are −10.98 MXN per share, whereas the estimation was −11.33 MXN resulting in a 3.08% surprise. The estimated earnings for the next quarter are −3.91 MXN per share. See more details about CARDLYTICS INC earnings.
CARDLYTICS INC revenue for the last quarter amounts to 1.38 B MXN despite the estimated figure of 1.40 B MXN. In the next quarter revenue is expected to reach 1.52 B MXN.
Yes, you can track CARDLYTICS INC financials in yearly and quarterly reports right on TradingView.
CDLX net income for the last quarter is −1.71 B MXN, while the quarter before that showed −417.74 M MXN of net income which accounts for −310.00% change. Track more CARDLYTICS INC financial stats to get the full picture.
Today CARDLYTICS INC has the market capitalization of 9.32 B, it has decreased by 1.60% over the last week.
No, CDLX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CDLX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CARDLYTICS INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 434.00 employees. See our rating of the largest employees — is CARDLYTICS INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CARDLYTICS INC technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CARDLYTICS INC stock shows the sell signal. See more of CARDLYTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CARDLYTICS INC future price: according to them, CDLX price has a max estimate of 294.10 MXN and a min estimate of 277.76 MXN. Read a more detailed CARDLYTICS INC forecast: see what analysts think of CARDLYTICS INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CARDLYTICS INC EBITDA is −596.62 M MXN, and current EBITDA margin is −11.05%. See more stats in CARDLYTICS INC financial statements.